H
H2U
Health service platform
About H2U
H2U is a digital health company that offers a data-driven platform for health management. The company's ecosystem includes the H2U pano platform, which is targeted at corporate clients and their employees, and iFit, a large weight-loss community in Taiwan. Through these platforms, H2U provides a range of services, including health data tracking, personalized health reports, and corporate wellness programs.
The company's business model appears to be a combination of B2B and B2C services. For its corporate clients, H2U offers a comprehensive suite of wellness solutions designed to improve employee health and well-being. This includes health checks, health promotion activities, and a platform for managing employee health data. For individual users, H2U provides access to a digital health platform and community support through its iFit brand.
H2U operates in the digital health and wellness market, with a significant presence in Taiwan. The company has successfully raised capital through a Series B funding round, indicating investor confidence in its business model and growth prospects. By leveraging technology and data, H2U aims to provide accessible and effective health solutions to both individuals and organizations.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- New Taipei, Taiwan
- Employees
- 58
- Open positions
- None listed
- Dealroom signal
- 78.2/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Personal Health
- Client focus
- b2c
- Investment activity
- 1 company, latest Aug 2024
- Capital deployed
- $6M
- Preferred round
- SEED
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Feb 2024 | $10M | $40M | GrandTech · Seoul Clinical Laboratories · Standard Foods · Leadgene Biomedical | ↗ |
| EARLY VCOther financing | Nov 2023 | — | — | InnoTherapy | ↗ |
Growth signals
Latest recorded traffic for H2U is 98K monthly website visits, up 42% over the last three months. H2U's team grew 13.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A11 investors entered at this stage
Foxconn Technology Group
ADATA Technology
Sharp
UDN Group
Topco Scientific
Wondercise
InnoTherapy
GrandTech- SLSeoul Clinical Laboratories
Standard Foods
Leadgene Biomedical
Other known investors1 additional known investor
SparkLabs Taiwan
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about H2U on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See H2U’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








